APCER Life Sciences

APCER Life Sciences, established in 1987 as part of the APC Group, is a global entity specializing in active pharmaceutical ingredients (APIs) and comprehensive life science services. With an initial focus on developing markets in India, China, and Southeast Asia for APIs and finished formulations, the company rapidly expanded its operational footprint. Offices were strategically established in Mumbai and Shanghai to cater to both API suppliers and buyers. As Asian pharmaceutical manufacturing quality increased, APC Group was well-positioned to serve Western markets, opening additional offices in Vietnam and Kazakhstan. The company's growth trajectory led to the formation of APCER Pharma Europe in 2007, enhancing its capabilities in safety and regulatory affairs, followed by the establishment of APCER Pharma Solutions in the US. Today, operating under the APCER Life Sciences brand, the organization provides a suite of safety, medical, regulatory, and technology services worldwide.

The company employs between 500 and 1,000 professionals across its 6 global locations, offering specialized services that include pharmacovigilance, medical information, regulatory technology, and auditing. APCER Life Sciences is dedicated to delivering cost-effective and agile solutions, bridging the gap between complex regulatory environments and pharmaceutical development. Meet APCER Life Sciences's team to understand the expertise driving these critical services. Their offerings are designed to ensure quality assurance and facilitate product development and market entry for clients.

APCER Life Sciences generates an annual revenue of $195.0M, positioning it as a significant player within the management consulting and business services sectors. Its competitive landscape includes firms like Aris Global and FreyrView more...